ライフサイエンスコーパス: vasculogenic mimicry

1 y to form tube-like structures on collagen ("vasculogenic mimicry").

2 ell dissemination by increasing invasion and vasculogenic mimicry.

3 cell invasion, migration, and inhibition of vasculogenic mimicry.

4 ddition to tumor cell plasticity as shown by vasculogenic mimicry.

5 adapted to a pseudoendothelial phenotype in vasculogenic mimicry.

6 sis that VE-cadherin is critical in melanoma vasculogenic mimicry.

7 in tyrosine kinases are involved in melanoma vasculogenic mimicry.

8 may not be applicable to tumors that express vasculogenic mimicry.

9 noma mitogen, laminin, a phenomenon known as vasculogenic mimicry.

10 In addition, Notch4 function in vasculogenic mimicry and anchorage-independent growth in

11 an essential role during the acquisition of vasculogenic mimicry and angiogenic properties associate

12 events that regulate the process of melanoma vasculogenic mimicry and identify new signal transductio

13 he ability of these tumor cells to engage in vasculogenic mimicry and neovascularization.

14 osome nucleation, motility, neoangiogenesis, vasculogenic mimicry, and osteoclastogenesis in the abse

15 MEF2C was found to mediate VEGF-induced vasculogenic mimicry, angiogenesis and migration/invasio

16 lial-cadherin, which plays a pivotal role in vasculogenic mimicry, as well as interleukin-8, fibronec

17 /or its cleavage fragments, are required for vasculogenic mimicry by aggressive melanoma cells.

18 y human melanoma cells in vivo and in vitro: vasculogenic mimicry," by Maniotis and colleagues, which

19 Vasculogenic mimicry describes a process where aggressiv

20 erized to invade aggressively and to undergo vasculogenic mimicry, expressed Mig-7.

21 Recently, the term "vasculogenic mimicry" has been used by our laboratory an

22 Vasculogenic mimicry is posited to contribute to melanom

23 lular and molecular determinants of melanoma vasculogenic mimicry is presented.

24 These data indicate that vasculogenic mimicry-like laminin networks, in addition

25 Mig-7 protein primarily co-localized with vasculogenic mimicry markers factor VIII-associated anti

26 EF2C on cell proliferation, and VEGF-induced vasculogenic mimicry, migration/invasion as well as angi

27 aggressive melanoma cells to participate in vasculogenic mimicry, particularly their expression of e

28 highly invasive uveal melanoma cells forming vasculogenic mimicry patterns after exposure to a lamini

29 tissue samples, uveal melanoma cells within vasculogenic mimicry patterns assumed the spindle A morp

30 s of primary uveal melanomas lacking looping vasculogenic mimicry patterns either did not stain for o

31 The histological detection of laminin-rich vasculogenic mimicry patterns in human primary uveal mel

32 on of human rather than mouse laminin in the vasculogenic mimicry patterns in this model demonstrates

33 Thus, the generation of vasculogenic mimicry patterns is accompanied by dampenin

34 Vasculogenic mimicry patterns were reconstructed from se

35 highly invasive uveal melanoma cells forming vasculogenic mimicry patterns, and genes associated with

36 Vasculogenic mimicry patterns, composed of human laminin

37 In primary melanomas containing looping vasculogenic mimicry patterns, strong osteopontin staini

38 After forming vasculogenic mimicry patterns, uveal melanoma cells inva

39 ith their increased invasion, migration, and vasculogenic mimicry plasticity.

40 echanical and molecular events that regulate vasculogenic mimicry provide opportunities for the devel

41 The unique patterning characteristic of vasculogenic mimicry provides an opportunity to design n

42 an carcinoma cells could engage in molecular vasculogenic mimicry reflected by their plasticity, comp

43 We recently have introduced the term vasculogenic mimicry to describe the unique ability of a

44 egulated, aggressive tumor cells was termed "vasculogenic mimicry" to emphasize their de novo generat

45 Vasculogenic mimicry (VM) describes the unique ability o

46 s found in patient tumor slices displaying a vasculogenic mimicry (VM) phenotype.

47 Tumor cell vasculogenic mimicry (VM) refers to the plasticity of ag

48 E-cadherin) and cytokeratins consistent with vasculogenic mimicry (VM), a process whereby tumour cell

49 display the ability to drive blood-perfused vasculogenic mimicry (VM), an alternative microvascular

50 in) and TIE1 and are associated with CD31(-) vasculogenic mimicry (VM), an established biomarker asso

51 alpha expression and an increase in CD144(+) vasculogenic mimicry (VM), leading to formation of chann

52 Vasculogenic mimicry (VM), the formation of matrix-rich

53 -2 expression with known prognostic factors, vasculogenic mimicry (VM), the mature vasculature (von W

54 ng vessel-like channels, a phenomenon termed vasculogenic mimicry (VM).

55 ternative microvascular circulation known as vasculogenic mimicry (VM).

56 nd participate in a PECAM1-dependent form of vasculogenic mimicry (VM).

57 rs have recently described a process termed "vasculogenic mimicry," which consists of the formation o